A comparative histological study on the effect of exposure to the smoke leaf extract of tobacco nicotiana, cannabis sativa and datura stramonium on the lungs of sprague-dawley rats
Keywords:
Cannabis sativa, Datura stramonium, Tobacco nicotiana, Lungs, Neutral buffered formalinAbstract
Smoking may exert compromising effects on several organ systems of the body, but those in the lungs are the most deleterious. Therefore the aim of the present study was to investigate some of the effects of inhalation of smoke extract of Tobacco nicotiana (Tobacco), Cannabis sativa and Datura stramonium (Jimson Weed) on the respiratory system, especially on the lungs. Twenty male Sprague Dawley rats were divided into four groups A-D. The rats in the control group (A) were not subjected to any of the smoke extracts, while the rats in groups B, C, and D were exposed to smoke from a completely burnt 0.74g leaf extract of Tobacco nicotiana, Cannabis sativa and Datura stramonium each for 5 minutes three times daily (7am, 10am, and 1pm) respectively. The duration of exposure in all the groups was for five days. All the rats were sacrificed by decapitation and the lung tissues were obtained from each animal using thoracotomy, blotted dry and fixed in buffered neutral formalin for histopathological analysis using Hematoxylin and Eosin (H&E) stain. In the lung tissue of the rats in the control group (A), the histological profile of the lungs were preserved, whereas in groups B, C, and D the histological outline of the tissues obtained revealed disruptive characteristics such as emphysema, evidence of bronchopneumonial features and fibrosis, occlusion of the bronchi, and dilation of the alveoli sac. In conclusion, the exposure of male Sprague Dawley rats to the smoke extract of Tobacco nicotiana (Tobacco), Cannabis sativa and Datura stramonium (Jimson Weed) has compromising effects on the histological integrity of the lungs of the rats and by extension may cause irreversible functional and morphological alterations in the lung tissue.
References
Wells, A.J., 1994. Passive Smoking as a Cause of Heart Disease. J. Am. Coll. Cardiol. 24, 546-554
Kawachi, I., Colditz, G.A., Speizer, F.E., 1997. A Prospective Study of Passive Smoking and Coronary Heart Disease.
Circulation. 95, 2374-2379.
Raupach, T., Schafer, K., Konstantinides, S., 2006. Secondhand smoke as an acute threat for the cardiovascular
system: a change in paradigm. Eur. Heart J. 27, 386-392.
Barnoya, J., Glantz, S.A., 2005. Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation.
, 2684-2698.
Blot, W.J., McLaughlin, J.K., Winn, D.M., Austin, D.F., Greenberg, R.S., Preston-Martin, S., Bernstein, L., Schoenberg,
J.B., Stemhagen, A., Fraumeni, J.F., 1988. Smoking and drinking in relation to oral and pharyngeal cancer,
Cancer Res. 48, 3282–3287.
Nichter, M., Cartwright, E., 1991. Saving the children for the tobacco industry. Medical Anthropology Quarterly. 5
(3),236–256.
Adams, I.B., Martin, B.R., 1996. Cannabis: pharmacology and toxicology in animals and humans. Addiction. 91,
–1614.
Ashton, C.H., 2001. Pharmacology and effects of cannabis: a brief review. Br. J. Psychiatry. 178, 101–106.
Klein, T.W., 2005. Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat. Rev. Immunol. 5, 400–411.
Novotny, M., Merli, F., Weisler, D., Fencl, M., Saeed, T., 1982. Fractionation and capillary gas chromatographic
mass spectrometric characterization of the neutral components in Cannabis sativa and tobacco smoke
concentrates. J. Chromatog. 238, 141–150.
Wu, T.C., Tashkin, D.P., Djahed, B., Rose, J.E., 1988. Pulmonary hazards of smoking Cannabis sativa as compared
with tobacco. N. Engl. J. Med. 318, 347–351.
Novak, J., Zitterl-Eglseer, K., Deans, S.G., Franz, C.M., 2001. Essential oils of different cultivars of Cannabis sativa L.
and their antimicrobial activity. Flavour and Fragrance J. 16 (4), 259–262.
Richard, H.U., Joseph, C.N., Joseph, M.D., 1997. Weeds of The Northeast, Ithaca, NY: Cornell University Press. pp.
-313.
Thun, H.L., Adams-Campbell, L., Boffetta, P., Buring, J., Feskanich, D., Flanders, W., Jee, S., 2008. Lung cancer
occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies. PLos. Medicine. 5 (9),
e185.
Guindon, G.E., Boisclair, D., 2003. Past, current and future trends in tobacco use. Washington DC: The International
Bank for Reconstruction and Development / the World Bank. pp. 13–16.
Richard, P., Lopez, A.D., Jillian, B., Michael, T., 2006. Mortality from Smoking in Developed Countries 1950–2000,
indirect estimates from national vital statistics. Oxford University Press. Pp. 9
Xie, E.F., Yang, Z.C., Wang, D., Fu, Q., Wei, J.J., 1998. A Rat Model of Smoke Inhalation Injury. Annals of Burns and
Fire Disasters – 11(2).
Dagher, A., Bleicher, C., Aston, J.A., Gunn, R.N., Clarke, P.B., Cumming, P., 2001. Reduced dopamine D1 receptor
binding in the ventral striatum of cigarette smokers. Synapse. 42(1), 48-53.
DiChiara, G., Acquas, E., Carboni, E., 1992. Drug Motivation and abuse: A neurobiological perspective. Ann. NY.
Acad. Sci. 654, 207-219.
National Institutes of Health Guide for the Care and Use of Laboratory Animals: DHEW Publication (NIH), revised.
Office of Science and Health Reports, DRR/NIH, Bethesda, USA, 1985.
Onarlioglu, B., Onarlioglu, T., Erdal, S., 1999. The Effect of Lead Inhalation on Rat Lung Morphology. Tr. J. Med. Sci.
, 617-622.
Moir, D., Rickert, W.S., Levasseur, G., 2008. A comparison of mainstream and sidestream Cannabis sativa and
tobacco cigarette smoke produced fewer than two machine smoking conditions. Chemical Research in
Toxicology. 21 (2), 494–502.
Ohlsson, A., Lindgren, J.E., Wahlen, A., Agurell, S., Hollister, L.E., Gillespie, H.K., 1980. Plasma delta-9
tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and
smoking. Clin Pharmacol Ther. 28(3), 409-416.
Gilman, A.G., Rall, T.W., Nies, A.S., Taylor, P., (eds.). Goodman and Gilman's (1998); The Pharmacological Basis of
Therapeutics, 8th Edition. New York: Pergamon Press.
Volkow, N.D., 2005. Research Report National Institute on Drug Abuse Series NIDA Research Report - Cannabis
sativa Abuse: NIH Publication No. 05-3859. Pain. Res. Manag. 10(A), 15a-22a.
Sridhar, K.S., Raub, W.A., Weatherby, N.L., Metsch, L.R., Surratt, H.L., Inciardi, J.A., Duncan, R.C., Anwyl, R.S.,
McCoy, C.B., 1994. Possible role of Cannabis sativa smoking as a carcinogen in the development of lung
cancer at a young age. J. Psychoac. Drug. 26(3), 285-288.
Hoffman, D., Brunnemann, K.D., Gori, G.B., Wynder, E.E.L., 1975. On the carcinogenicity of Cannabis sativa smoke.
In: V.C. Runeckles, ed., Recent Advances in Phytochemistry. New York: Plenum.
Cohen, S., 1981. Adverse effects of Cannabis sativa: Selected issues. Annals of the New York Academy of Sciences.
, 119-124.
Cahalane, M., Demling, R., 1984. Early respiratory abnormalities from smoke inhalation. JAMA, 251, 771–773.
Lentz, C., Peterson, H., 1997. Smoke inhalation is a multilevel insult to the pulmonary system. Curr. Opin. Pulm.
Med. 3, 221– 226.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2012 D. A. Adekomi, A. A. Tijani, A. M. Afodun, K. K. Quadri
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
